Silibinin: a potential old drug for cancer therapy
Xingxing Zhu(University of Glasgow), Qiang He(Capital Medical University), Hai Zou(Shanghai Medical College of Fudan University), Lin-Yan Qian(Zhejiang Provincial People's Hospital), Ya-Hui Ding(Zhejiang Provincial People's Hospital), Yi Wu(Zhejiang Provincial People's Hospital)
Cited by 64
Related Papers
Fe<sub>3</sub>O<sub>4</sub>/Ag/Bi<sub>2</sub>MoO<sub>6</sub> Photoactivatable Nanozyme for Self‐Replenishing and Sustainable Cascaded Nanocatalytic Cancer Therapy
|Advanced Materials|2021|250
Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
|Scientific Reports|2016|138
Energy Metabolism Disorder as a Contributing Factor of Rheumatoid Arthritis: A Comparative Proteomic and Metabolomic Study
|PLoS ONE|2015|112